logo
Plus   Neg
Share
Email

Rhoen-Klinikum Acquires Minority Share In Software Provider Tiplu GmbH

German hospital operator Rhoen-Klinikum AG (RKKPF.PK), said Wednesday that it has acquired a minority share in software provider Tiplu GmbH in Hamburg. Both parties have agreed to keep financial details of the transaction confidential.

Rhoen-Klinikum noted that the acquisition of a minority stake in Tiplu marks an important step in its digitalisation strategy.

Founded in 2016 Tiplu has specialised in accompanying diagnosis-related group or DRG-coding and safeguarding revenues by applying semantic text analyses to hospital documents, such as medical reports, laboratory findings or OP documentation.

Rhoen-Klinikum said it uses Tiplu's Momo coding software for comprehensive and performance-related billing, to safeguard revenues and to review the duration of hospital stays.

"Tiplu GmbH's aims of helping to further automate and optimise the documentation and coding processes by applying semantic text analyses are similar to ours. We can further improve Momo's performance by linking the billing expertise in our corporate hospitals with the leading technology in the market and Tiplu's reference material for the benefit of all our patients and clients," Stephan Holzinger, Rhoen-Klinikum's CEO, said.

Rhoen-Klinikum noted that its already relies on a series of digital applications that intend to assist physicians and nurses in their work, further enhance the care of patients and improve the documentation of rendered services.

The Medical Cockpit of Rhoen-Klinikum offers medical staff a semantic search of all relevant information in medical reports, OP reports and x-ray diagnoses. The company's staff is thus given a faster comprehensive overview of the patient's history.

The Medical Cockpit is integrated in the clinical information system and has access to the company's universal archive.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT